GSA Capital Partners’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$275K Buy
9,319
+558
+6% +$14.3K 0.02% 1354
2026
Q1
$205K Sell
8,761
-58,831
-87% -$1.07M 0.01% 1445
2025
Q4
$959K Buy
67,592
+19,882
+42% +$376K 0.08% 384
2025
Q3
$1.18M Buy
47,710
+13,633
+40% +$304K 0.1% 301
2025
Q2
$773K Buy
34,077
+9,990
+41% +$237K 0.05% 629
2025
Q1
$730K Buy
+24,087
New +$918K 0.07% 540
2021
Q3
– Sell
-6,870
Closed -$431K – 1368
2021
Q2
$431K Buy
+6,870
New +$431K 0.05% 724
2019
Q1
– Sell
-34,976
Closed -$899K – 1394
2018
Q4
$899K Buy
+34,976
New +$1.21M 0.1% 259
2016
Q4
– Sell
-6,566
Closed -$325K – 1718
2016
Q3
$325K Buy
+6,566
New +$342K 0.02% 1316
2014
Q1
– Sell
-6,065
Closed -$287K – 1532
2013
Q4
$287K Sell
6,065
-3,135
-34% -$136K 0.02% 1233
2013
Q3
$363K Buy
9,200
+3,000
+48% +$111K 0.03% 1008
2013
Q2
$205K Buy
+6,200
New +$201K 0.02% 1077

Other funds holding ACHC

GSA Capital Partners's ACHC Position: Q2 2026 in Review

GSA Capital Partners increased its Acadia Healthcare (ACHC) stake by 6.4% in Q2 2026, buying an estimated $14.3K and bringing the position to 9,319 shares worth $275K. The position accounts for 0.02% of the portfolio, ranked #1354.

GSA Capital Partners first reported a position in ACHC in Q2 2013 and has held it in 12 quarters since. The position peaked at $1.18M in Q3 2025. 313 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • GSA Capital Partners held 9,319 shares of Acadia Healthcare worth $275K as of Q2 2026.
  • GSA Capital Partners bought 558 Acadia Healthcare shares in Q2 2026, an estimated $14.3K.
  • Acadia Healthcare made up 0.02% of GSA Capital Partners's portfolio in Q2 2026, its #1354 holding.
  • GSA Capital Partners first reported a position in Acadia Healthcare in Q2 2013 and has held it in 12 quarters since.
  • GSA Capital Partners's Acadia Healthcare position peaked at $1.18M in Q3 2025.
  • 313 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.